Nicotine exposure alters human vascular smooth muscle cell phenotype from a contractile to a synthetic type

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 464-470

  Yoshiyama, Shinji ^a   Chen, Zhenyi ^a   Okagaki, Tsuyoshi ^b   Kohama, Kazuhiro ^c   Nasu Kawaharada, Ritsuko ^d   Izumi, Takashi ^a   Ohshima, Noriyasu ^a   Nagai, Takeharu ^e   Nakamura, Akio ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

^c MUSASHINO UNIVERSITY   (Japan)

^d TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Contractile type; Nicotine; Synthetic type; Vascular smooth muscle

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOSIN II; NICOTINE; NICOTINIC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

AORTA MEDIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPOSURE; GENE EXPRESSION PROFILING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PHENOTYPE; PRIMARY CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 84908498924     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.019     Document Type: Article

References (33)

1. Jonas M.A., Oates J.A., Ockene J.K., et al. Statement on smoking and cardiovascular disease for health care professionals. American Heart Association. Circulation 1992, 86:1664-1669.
2. Witteman J.C., Grobbee D.E., Valkenburg H.A., et al. Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women. Circulation 1993, 88:2156-2162.
3. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
4. Heeschen C., Jang J.J., Weis M., et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 2001, 7:833-839.
5. Brüggmann D., Lips K.S., Pfeil U., et al. Multiple nicotinic acetylcholine receptor alpha-subunits are expressed in the arterial system of the rat. Histochem Cell. Biol. 2002, 118:441-447.
6. Brüggmann D., Lips K.S., Pfeil U., et al. Rat arteries contain multiple nicotinic acetylcholine receptor α-subunits. Life Sci. 2003, 72:2095-2099.
7. Luozzo G.D., Pradhan S., Dhadwal A.K., et al. Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration. Atherosclerosis 2005, 178:271-277.
8. Kanda Y., Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the EGFR-ERK pathway in rat vascular smooth muscle cells. Life Sci. 2007, 80:1409-1414.
9. Cucina A., Fuso A., Coluccia P., et al. Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. J.Surg. Res. 2008, 150:227-235.
10. Yoshiyama S., Horinouchi T., Miwa S., et al. Effect of cigarette smoke components on vascular smooth muscle cell migration toward platelet-derived growth factor BB. J.Pharmacol. Sci. 2011, 115:532-535.
11. Saito K., Chang Y.-F., Horikawa K., et al. Luminescent proteins for high-speed single-cell and whole-body imaging. Nat. Commun. 2012, 3:1262-1269.
12. Armstrong D.W., Wang X., Ercal N. Enantiomeric composition of nicotine in smokeless tobacco, medicinal products, and commercial reagents. Chirality 1998, 10:587-591.
13. Holmberg J.T., Thulesius O., Gjöres J.E. Effect of nicotine on isolated human blood vessels. Acta Chir. Scand. Suppl. 1976, 465:71-73.
14. Carty C.S., Huribal M., Marsan B.U., et al. Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells. J.Vasc. Surg. 1997, 25:682-688.
15. Stein J.J., Seymour K.A., Maier K.G., et al. The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin. Am. J. Surg. 2011, 202:545-548.
16. Li S., Zhao T., Xin H., et al. Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine. J.Pharmacol. Sci. 2004, 94:334-338.
17. Gu Z., Fonseca V., Hai C.-M. Nicotinic acetylcholine receptor mediates nicotine-induced actin cytoskeletal remodeling and extracellular matrix degradation by vascular smooth muscle cells. Vasc. Pharmacol. 2013, 58:87-97.
18. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2002, 421:384-388.
19. Santanam N., Thornhill B.A., Lau J.K., et al. Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis 2012, 225:264-273.
20. Bryant B., Xu J., Audige V., et al. Cellular basis for the olfactory response to nicotine. ACS Chem. Neurosci. 2010, 1:246-256.
21. Tang Y., Yang X., Friesel R.E., et al. Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells. J.Vasc. Res. 2011, 48:485-494.
22. Thyberg J., Palmberg L., Nilsson J., et al. Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. Differentiation 1983, 25:156-167.
23. Worth N.F., Rolfe B.E., Song J., et al. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil. Cytoskelet. 2001, 49:130-145.
24. Benowitz N.L. Pharmacology of nicotine: addiction and therapeutics. Annu Rev. Pharmacol. Toxicol. 1996, 36:597-613.
25. Aikawa M., Sivam P.N., Kuro-o M., et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circulation 1993, 73:1000-1012.
26. Owens G.K., Thompson M.M. Developmental changes in isoactin expression in rat aortic smooth muscle cells invivo. Relationship between growth and cytodifferentiation. J.Biol. Chem. 1986, 261:13373-13380.
27. Ueki N., Sobue K., Kanda K., et al. Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc. Natl. Acad. Sci. U S A. 1987, 84:9049-9053.
28. Gimona M., Sparrow M.P., Strasser P., et al. Calponin and SM 22 isoforms in avian and mammalian smooth muscle. Absence of phosphorylation invivo. Eur. J. Biochem. 1992, 205:1067-1075.
29. Doi H., Iso T., Sato H., et al. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J.Biol. Chem. 2006, 281:28555-28564.
30. English J., Pearson G., Wilsbacher J., et al. New insights into the control of MAP kinase pathways. Exp. Cell. Res. 1999, 253:255-270.
31. Huang C. MAP kinases and cell migration. J.Cell. Sci. 2004, 117:4619-4628.
32. Nelson P.R., Yamamura S., Mureebe L., et al. Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J.Vasc. Surg. 1998, 27:117-125.
33. Hopkins P.N. Molecular biology of atherosclerosis. Physiol. Rev. 2013, 93. 1317-1542.